C
China Pharma Holdings, Inc. (CPHI)
ASE – Real Time Price. Currency in USD
0.61
-0.01 (-1.54%)
At close: Jun 26, 2026, 3:59 PM EDT
0.61
-0.00 (-0.78%)
After-hours: Jun 26, 2026, 7:44 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
0.61
-0.01 (-1.54%)
At close: Jun 26, 2026, 3:59 PM EDT
0.61
-0.00 (-0.78%)
After-hours: Jun 26, 2026, 7:44 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Total debt $3.6M significantly exceeds cash reserves ($168.5K), raising financial stability concerns
Total current liabilities $7.3M surpass Total current assets $2.0M, signaling liquidity issues
Debt-to-equity ratio (0.1) is well below the industry average (-0.8), showcasing prudent financial management
Interest coverage ratio (-42.9x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$55.3K limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.28 | 2.52 | 3.0 | |
| Quick ratio | 0.07 | 1.78 | 1.0 | |
| Debt to Equity | 0.10 | -0.80 | 9.0 | |
| Debt to Assets | 0.08 | 0.73 | 9.0 | |
| Interest coverage | -42.92 | -13.90 | 1.0 | |
| Weighted average score | 4.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 8M | 7M | 5M | 4M | 4M |
| Gross Profit | -530K | -505K | -2M | -984K | -1M |
| Operating Income | -4M | -3M | -5M | -3M | -4M |
| Net Income | -4M | -3M | -5M | -3M | -4M |
| EBITDA | -848K | 2K | -2M | -2M | -1M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -19.77 | 6.46 | N/A | -136.48 | 2.0 |
| Y/Y | -13.43 | -45.51 | N/A | 58.11 | 3.3 |
| 3y average | -19.11 | 0.46 | N/A | 56.62 | 3.5 |
| 5y average | -16.9 | -6.8 | N/A | 33.15 | 3.3 |
| Weighted average score | 3.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |